Table 1.
Clinical characteristics of kidney transplant recipients.
| Parameters | Subjects (n = 79) |
|---|---|
| Time after transplantation, years | 5.4 ± 3.7 |
| Age, years | 54 ± 13 |
| Male, n (%) | 56 (71%) |
| Body mass index, kg/m2 | 27.2 ± 5.2 |
| 3-month eGFR, ml/min/1,73 m2 | 54 ± 21 |
| 6-month eGFR, ml/min/1,73 m2 | 52 ± 19 |
| 12-month eGFR, ml/min/1,73 m2 | 52 ± 19 |
| eGFR at exploration visit, ml/min/1,73 m2 | 52 ± 22 |
| Donor age, years | 48 ± 14 |
| Cold ischemia time, hours | 15 ± 7 |
| Immunosuppressive agent, n (%) | |
| Cyclosporine | 18 (23%) |
| Tacrolimus | 59 (75%) |
| Mycophenolate Mofetil | 70 (89%) |
| Hypertension, n (%) | 73 (92%) |
| Diabetes, n (%) | 16 (20%) |
| Statins, n (%) | 49 (62%) |
Data are mean ± SD or n (%).eGFR: estimated glomerular filtration rate.